Literature DB >> 10489491

Respiratory syncytial virus infection in young Malaysian children.

P Chan1, A Goh.   

Abstract

UNLABELLED: Respiratory syncytial virus (RSV) is the most important agent causing respiratory illness in the young paediatric age group.
OBJECTIVE: To determine the clinical profile and risk factors for respiratory distress in young Malaysian children with RSV infection.
METHOD: The study was a retrospective review of 185 children below the age of 24 months hospitalised with RSV infection. Respiratory distress at admission was categorised into mild, moderate and severe using a modified respiratory distress assessment instrument (RDAI) score.
RESULTS: RSV infection occurred most frequently in the 3-6 months age group with a male predominance. A small number of patients had extrapulmonary symptoms of diarrhoea (8%) and seizures (7%). Forty-seven patients (25%) had an underlying illness. The majority of patients (63%) had mild respiratory distress. All patients (8%) with severe respiratory distress required intensive care and 80% of them required assisted ventilation. The overall mean duration of hospital stay was 7.0 +/- 5.0 days. There was only one death. Risk factors associated with respiratory distress included age less than 3 months, a family history of bronchial asthma and presence of an underlying disease.
CONCLUSION: The majority of Malaysian children with RSV infection had a mild illness but a small number of them who developed severe illness had a higher incidence of respiratory failure requiring assisted ventilation.

Entities:  

Mesh:

Year:  1999        PMID: 10489491

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  1 in total

1.  The clinical respiratory score predicts paediatric critical care disposition in children with respiratory distress presenting to the emergency department.

Authors:  Kanwal Nayani; Rubaba Naeem; Owais Munir; Naureen Naseer; Asher Feroze; Nick Brown; Asad I Mian
Journal:  BMC Pediatr       Date:  2018-10-30       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.